Global Interventional Pulmonology Market-Industry Analysis and Forecast (2019-2027)
Global Interventional Pulmonology Market was valued US$ xx Mn in 2019 and is expected to grow US$ xx Mn by 2027, at a CAGR of 4.6% during the forecast period.
Global Interventional Pulmonology Market
The report has analyzed the revenue impact of the COVID-19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.
Interventional pulmonology is a division of medical science that deals with an invasive medical technique for the diagnosis, treatment, and palliation of different types of pulmonary disorders. Interventional pulmonology procedures include the usage of various image-guided techniques, like computed tomography, fluoroscopy, and ultrasound to diagnose and treat the particular site affected by pain or cancer. Interventional pulmonology procedure is most commonly implemented with other cancer treatments, like surgery, chemotherapy, and radiation therapy. These techniques offer numerous advantages, such as quicker recovery, shorter hospital stay, minimal side effects, and more specific and accurate treatment as compared to other therapeutic procedures.
The rising occurrence of lung cancer and chest regarding medical conditions is driving the interventional pulmonology market growth. Several consciousness campaigns about asthma, COPD, and other pulmonary diseases assumed by governments and healthcare providers are driving the market growth. Lung cancer is one of the leading reasons for death globally. As stated by the World Health Organization (WHO), lung cancer accounted for around 3 million deaths in 2018.
Advanced bronchoscopy procedures like electromagnetic navigation bronchoscopy are used for augmenting standard bronchoscopy with the use of a 3D roadmap of the lungs with real-time data. The electromagnetic navigation bronchoscopy is expected to protect higher reimbursements, which will drive the growth of the interventional pulmonology market. Companies such as Olympus are continuously launching new products in the interventional pulmonology market. Likewise, companies are struggling hard to develop and achieve regulatory approvals for new procedures and interventions. For example, Olympus’ Spiration Valve was newly permitted for emphysema by the FDA.
Advanced interventional pulmonology products allow retailers to upsell and tap the ever-growing interventional pulmonology market, specifically in developed regions. Collaborations with hospitals and retailers are one more marketing strategy that is being adopted by significant players in the interventional pulmonology market. On the other hand, the existence of substitute methods is expected to hamper the market growth.
By region, North America is expected to account for the largest market shares of the global market because of the large population suffering from chronic lung cancer, chronic obstructive pulmonary disorders, airway stricture, and airway related disorders. Also, significant approval of invasive surgeries for the effective management of airway disorders, well-established healthcare infrastructure, and the adoption of technologically advanced interventional pulmonology products are expected to boost up the growth of the market in the North America region in the future. The interventional pulmonology market in the Asia Pacific is expected to grow at the highest CAGR during the forecast period (2019-2027), thanks to the rise in occurrence of cancer in the vastly populous countries of India and China, fast-changing healthcare systems, several government initiatives to improve overall healthcare, and increased per capita healthcare expenditure.
The objective of the report is to present a comprehensive analysis of the Global Interventional Pulmonology Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Interventional Pulmonology Market dynamics, structure by analyzing the market segments and project the Global Interventional Pulmonology Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Interventional Pulmonology Market make the report investor’s guide.
For More Information Visit @:
Scope of the Global Interventional Pulmonology Market
Global Interventional Pulmonology Market, By Product Type
• Respiratory Endotherapy Devices
• ENB Systems
• Airway Stents
• Bronchial Thermoplasty Systems
• Pleural Catheters
• Endobronchial Valves
Global Interventional Pulmonology Market, By Indication
• Lung Cancer
• Foreign Body Extraction
• Tracheal And Bronchial Stenosis
Global Interventional Pulmonology Market, By End-user
• Pulmonology Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers
Global Interventional Pulmonology Market, By Region
• North America
• Asia Pacific
• Middle East & Africa
• South America
Key players operating in the Global Interventional Pulmonology Market
• Boston Scientific Corporation
• Olympus Corporation
• FUJIFILM Corporation
• Becton, Dickinson and Company
• Smiths Group plc.
• Cook Medical
• PENTAX Medical
• Clarus Medical LLC
• HUGER Medical Instrument Co., Ltd.
• Richard Wolf Corporation
• Karl Storz
• Taewoong Medical Co., Ltd
• ELLA – CS, s.r.o.
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Name: Lumawant Godage
Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.
Address: Pune, Maharashtra 411051, India.